NCT00483470View on ClinicalTrials.gov

Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster Dose

PHASE3CompletedINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

August 31, 2008

Conditions
Hepatitis A
Interventions
BIOLOGICAL

Hepatitis A vaccine AVAXIM 80U

0.5 mL, Intramuscular

BIOLOGICAL

Hepatitis A vaccine (HAVRIX 720)

0.5 mL, Intramuscular

Trial Locations (3)

530021

Nanning

541001

Guilin

541800

Yongfu Country

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00483470 - Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster Dose | Biotech Hunter | Biotech Hunter